Skip to content

Clinical trials

Terminated Phase 2 Psychotic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Phase 2 Status: Terminated Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20101
20131
20141
20151
20172
20182
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch Health Americas, Inc.1
Beth Israel Deaconess Medical Center1
Boehringer Ingelheim1
Haukeland University Hospital1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Mediti Pharma Inc.1
New York State Psychiatric Institute1
Northwestern University1
Orexigen Therapeutics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders14
Schizophrenia11
Alzheimer Disease1
Cognitive Dysfunction1
Dementia1
DiGeorge Syndrome1
Hypertension1
Mental Disorders1
Obesity1
Psychomotor Agitation1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.